Crispr Therapeutics shares owned by Kestra Advisory Services
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Kestra Advisory Services
from 13F filings
Historical chart of Kestra Advisory Services investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Kestra Advisory Services consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Kestra Advisory Services
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $1.2M | 19k | 64.81 |
| 2025-06-30 | $708k | 15k | 48.64 |
| 2025-03-31 | $560k | 16k | 34.03 |
| 2024-12-31 | $630k | 16k | 39.36 |
| 2024-09-30 | $572k | 12k | 46.98 |
| 2024-06-30 | $870k | 16k | 54.01 |
| 2024-03-31 | $1.1M | 16k | 68.16 |
| 2023-12-31 | $714k | 11k | 62.60 |
| 2023-09-30 | $256k | 5.6k | 45.39 |
| 2023-06-30 | $342k | 6.1k | 56.14 |
| 2023-03-31 | $272k | 6.0k | 45.23 |
| 2022-12-31 | $255k | 6.3k | 40.65 |
| 2022-09-30 | $440k | 6.7k | 65.30 |
| 2022-06-30 | $415k | 6.8k | 60.70 |
| 2022-03-31 | $340k | 5.4k | 62.85 |
| 2021-12-31 | $326k | 4.3k | 75.67 |
| 2021-09-30 | $1.4M | 13k | 111.93 |
| 2021-06-30 | $2.0M | 12k | 161.89 |
| 2021-03-31 | $729k | 6.0k | 121.89 |
| 2020-12-31 | $1.7M | 11k | 161.59 |